Tuesday, August 29, 2017

FDA's Gottlieb Wants To Rein In Risk Info In Drug Ads, But Will He Succeed?

Should the huge list of side effects included in every prescription drug ad be shortened? The FDA wants your opinion.

from Forbes Real Time //www.forbes.com/sites/arleneweintraub/2017/08/29/fdas-gottlieb-wants-to-rein-in-risk-info-in-drug-ads-but-will-he-succeed/
via IFTTT

No comments:

Post a Comment